Kasra Amirdelfan, MD, serves as Vice President, Clinical Affairs on the Executive Board of the American Society of Pain & Neuroscience (ASPN). He is Director of Clinical Research at Boomerang Healthcare, based in Walnut Creek, California, where his practice centers on interventional pain management and neuromodulation, with particular focus on spinal cord stimulation, spinal disorders, and stem cell technologies. He is also a founding partner of IPM Medical Group and one of the founders of the Pacific Spine & Pain Society (PSPS).
Dr. Amirdelfan earned his medical degree from Texas A&M University College of Medicine and completed his residency at John Peter Smith Hospital in Fort Worth, Texas. He went on to complete a fellowship in Interventional Pain Medicine at Pacific Pain Treatment Centers in San Francisco under Dr. Elliot Krames, in collaboration with California Pacific Medical Center. He is board certified by the American Board of Pain Medicine.
A prolific investigator in spinal cord stimulation research, Dr. Amirdelfan served as first author of the SENZA-RCT 12-month quality-of-life outcomes study, a landmark randomized controlled trial of 10 kHz spinal cord stimulation published in Quality of Life Research (2018), and has contributed as an investigator to other multicenter randomized trials in the field, including the BENEFIT-02 study of multiphase spinal cord stimulation published in Neuromodulation (2023). He has authored numerous peer-reviewed publications on spinal cord stimulation and interventional pain management and lectures widely on these topics at regional and national meetings. He has also served as Department Chair of Pain Medicine at hospitals in the East Bay region of California.
Newsletter contributions